Flora Peyvandi/LinkedIn
Sep 14, 2026, 07:45
Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
“Hemophilia care still has gaps worldwide. Restrictions can lead to low-dose prophylaxis and less protection.
Innovative therapies should close these gaps, ensuring every patient has access to effective, personalised care.
Let’s invest in health, dignity and well-being – not war.”
Other posts featuring Flora Peyvandi on Hemostasis Today.
-
Sep 14, 2026, 15:53Leonard Valentino: Advancing a New Model of Patient-Led Research
-
Sep 14, 2026, 15:48Adishwar Rao: LAAC vs Oral Anticoagulation in Atrial Fibrillation
-
Sep 14, 2026, 15:36Lesley Van Wyk: Hemolytic Anemia Quick Revision – Tips and Tricks
-
Sep 14, 2026, 15:35Maha Othman: ISTH-BAT Reference Ranges Validated Across Five Continents in Children
-
Sep 14, 2026, 15:30Umberto Pensato։ Left Ventricular Dysfunction and DOAC Benefit in ESUS
-
Sep 14, 2026, 15:22Meral Kayikcioglu: Why Do Women and Men Differ in LDL-C Management?
-
Sep 14, 2026, 15:22James Crowley: The Complex Role of CRP in Cardiovascular Risk and Atherosclerosis
-
Sep 14, 2026, 15:16Factor XIII Deficiency An Often-Missed Bleeding Disorder
-
Sep 14, 2026, 15:07Raffaele Piccolo: Heparin Against Jellyfish Venom?